Genomic testing in pediatric epilepsy

Drew M. Thodeson, Jason Y. Park

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Genomic testing has become routine in the diagnosis and management of pediatric patients with epilepsy. In a single test, hundreds to thousands of genes are examined for DNA changes that may not only explain the etiology of the patient’s condition but may also inform management and seizure control. Clinical genomic testing has been in clinical practice for less than a decade, and because of this short period of time, the appropriate clinical use and interpretation of genomic testing is still evolving. Compared to the previous era of single-gene testing in epilepsy, which yielded a diagnosis in <5% of cases, many clinical genomic studies of epilepsy have demonstrated a clinically significant diagnosis in 30% or more of patients tested. This review will examine key studies of the past decade and indicate the clinical scenarios in which genomic testing should be considered standard of care.

Original languageEnglish (US)
JournalCold Spring Harbor Molecular Case Studies
Volume5
Issue number4
DOIs
StatePublished - 2019

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Genetics
  • Genetics(clinical)

Fingerprint Dive into the research topics of 'Genomic testing in pediatric epilepsy'. Together they form a unique fingerprint.

Cite this